BARDA and Rafa Laboratories Collaborate to Advance Development of Pediatric Atropine Autoinjectors and Boost National Preparedness

As part of ongoing national preparedness efforts for emergencies involving nerve agents, BARDA is collaborating with Rafa Laboratories, LTD to develop an improved version of the company’s prefilled atropine autoinjector to treat nerve agent and insecticide poisoning in pediatric populations.

Read the full press release from BARDA.